SSY Group (HKG:2005) obtained production and registration approval for two products from China's National Medical Products Administration, a Tuesday Hong Kong bourse filing said.

The approvals are for Levofloxacin Eye Drops used to treat blepharitis, meibomianitis, dacryocystitis, and conjunctivitis among other illnesses, and Compound Sodium Picosulfate Granules used in bowel cleansing preparation before colonoscopy, X-ray, and surgery.